New drug shows promise for eye nerve inflammation
NCT ID NCT04762017
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 27 times
Summary
This study tested a new drug called OCS-05 in 36 people with acute optic neuritis, a condition that causes sudden vision loss due to nerve inflammation. The main goal was to see if the drug is safe and tolerable compared to a placebo, while participants also received standard care. Researchers measured eye health by tracking changes in retinal layers over six months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPTIC NEURITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CHU - Nice
Nice, 06000, France
-
CIC Neurosciences - La Pitié Salpêtrière
Paris, 75013, France
-
Foundation Rothschild
Paris, 75019, France
-
Hospices Civils de Lyon
Lyon, 69677, France
Conditions
Explore the condition pages connected to this study.